Investing Profile

Geraldine Paulus

InvestorVC
Senior Associate at MPM BioImpact
mpmcapital.com/team/dr-gerald...Cambridge, Massachusetts
Photo of Geraldine Paulus, Senior Associate at MPM BioImpact

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Massachusetts Institute of Technology Network
514 CONNECTIONS
Flagship Pioneering Network
81 CONNECTIONS
Harvard Medical School Network
65 CONNECTIONS
BASF Network
60 CONNECTIONS
MIT Network
51 CONNECTIONS
MPM BioImpact Senior Associate
$100K - $5.0M
$1.5M
Venture Intern, Partners Innovation Fund (PIF) Mass General Brigham InnovationPresent
Consultant for VL51, a Flagship Pioneering backed company, now acquired by Kintai Therapeutics Flagship VenturesPresent
Senior Associate MPM BioImpactPresent
Co-Founder, SVP of Corporate Development and Operations Crossbow Therapeutics, IncPresent
Co-Founder, VP of Corporate Development and Operations Crossbow Therapeutics, Inc2022 - 2025
Co-founder, Head of Corporate Development and Strategy Crossbow Therapeutics, Inc2021 - 2022
Senior Associate MPM Capital2020 - 2022
Director of Research and Analytics The Engine2020 - 2020
Associate The Engine2018 - 2020
Postdoctoral Research Fellow Harvard Medical School2013 - 2018
Consultant for VL51, a Flagship Pioneering backed company, now acquired by Kintai Therapeutics Flagship Pioneering2018 - 2018
Venture Intern, Partners Innovation Fund (PIF) Partners HealthCare Innovation2017 - 2018
Chemical Engineering Graduate student MIT School of Engineering2008 - 2013
Intern (process engineer) BASF2005 - 2005
MIT Doctor of Philosophy (Ph.D.) Chemical Engineering
Katholieke Universiteit Leuven Master of Science (MS) Chemical Engineering
BASF Master of Science (MS) Chemical Engineering
KU Leuven Master of Science (MS) Chemical Engineering
MIT Doctor of Philosophy (Ph.D.) Chemical Engineering
Massachusetts Institute of Technology Doctor of Philosophy (Ph.D.) Chemical Engineering
Sign in with Google →
Sign in with Google →